Morgan Stanley, Truist Cautious on DexCom (DXCM) Cites Weaker Gross Margins, Modest Q3 Beat

DexCom Inc. (NASDAQ:DXCM) is one of the best QQQ stocks to buy according to Wall Street analysts. On November 10, Morgan Stanley cut the price target on DexCom to 63from63 from 89, while maintaining an Overweight rating on the shares. Additionally, on November 3, Truist also lowered the firm’s price target on DexCom to 82from82 from 94 with a Buy rating on the shares. Truist noted that the company achieved only a modest beat on its Q3 2025  earnings and revenue targets. However, the reported gross margins were we ...